CSC
ICPT

Caldwell Sutter Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Caldwell Sutter Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$1.85K – 987
2023
Q3 		$1.85K Hold
100
– – ﹤0.01% 747
2023
Q2 		$1.11K Buy
+100
New +$1.39K ﹤0.01% 783

Caldwell Sutter Capital's ICPT Position: Q4 2023 in Review

Caldwell Sutter Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 100 shares — an estimated $1.85K sold.

Caldwell Sutter Capital first reported a position in ICPT in Q2 2023 and held it in 2 quarters. The position peaked at $1.85K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Caldwell Sutter Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Caldwell Sutter Capital sold 100 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.85K.
  • Caldwell Sutter Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2023 and held it in 2 quarters.
  • Caldwell Sutter Capital's Intercept Pharmaceuticals, Inc. position peaked at $1.85K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Caldwell Sutter Capital's 13F filing for Q4 2023, filed 19 Jan 2024.